• İstanbul Üniversitesi Tıp Fakültesi Çocuk Nöroloji Anabilim Dalı Kat 3 ve 5 PK 34293 Çapa-İstanbul
Soru Sor

Bildiriler

  • Bildiriler
6497 Okunma
  1. Yalçın AD, M. Özgüzel, Z. Yapici, S. Öztürk ve H. Forta, “Effect of Corticosteroid Theraphy in Landau-Kleffner Syndrome,” 3rd Mediterranean Epilepsy Conference, Istanbul, October 24-26, 1994.
  2. Yapici Ucgul Z, M. Mert, M. Barlas ve M. Eraksoy, “Monozygotic twins with Bardet-Biedel syndrome: MRI findings,” 2nd Congress of the European Paediatric Neurology Society, 8-11October, 1997 - Maastricht, The Netherlands. Eur J Paediatr Neurol Vol. 1, N 2/3, P160, 1997.
  3. Yapici Ucgul Z, M. Eraksoy, M. Barlas ve H. Özcan, “Bilateral basal ganglia lesions in childhood: clinical and radiological findings,” 2ndCongress of the European Paediatric Neurology Society, 8-11 October. 1997 - Maastricht, The Netherlands. Eur J Paediatr Neurol Vol. 1, N 2/3, P161, 1997.
  4. Yapici Ucgul Z, A. Ucgul, E. Deniz, M. Barlas ve M. Eraksoy, “Cystic leucoencephalopathy with megalenceplay in two siblings: Clinical characteristics, MRI and MRS findings,” 8th International Child Neurology Congress, September 13-17, 1998 - Lyubljana, Slovenia. Brain Dev Vol. 20, N 6, 376, 175 GEN T, 1998.
  5. Yapici Ucgul Z, A. Üçgül, E. Deniz, M. Barlas ve M. Eraksoy, “Inflammatory demyelinating, steroid responsive encephalopathy in three children presented with hemiparesis,” 8th International Child Neurology Congress, September 13-17, 1998 - Lyubljana, Slovenia. Brain Dev Vol. 20, N 6, 402, 276 INF T, 1998.
  6. Eraksoy M, GA. Demir, Z. Yapici Ucgul, E. Deniz, M. Barlas, Ç. Bayındır, O. Barlas, A. Sav, M. Özek, GS. Direskeneli, H. Özcan ve C. Özdemir, “Multipl sclerosis in childhood: a prospective study,” 8th International Child Neurology Congress, September 13-17, 1998 - Lyubljana, Slovenia. Brain Dev Vol. 20, N 6, 427, 374 DCB T, 1998.
  7. Deniz E, Z. Yapici Ucgul, B. Madi, M. Eraksoy ve H. Özcan, “MR Findings of children with cerebral palsy,” 8th International Child Neurology Congress, September 13-17, 1998 - Lyubljana, Slovenia. Brain Dev Vol. 20, N 6, 405, 290 CP T, 1998. 
  8.  Hüner G, Z. Yapici Ucgul, A. Sewell, T. Baykal, N. Aydınlı, M. Eraksoy, HJ. Böhler ve M. Demirkol, “L-2-Hydroxyglutaric Aciduria: Findings in 4 Turkish Patients,” SSIEM 37th Annual Symposium, 7-10 September, 1999, Genova, Italy. J Inherit Met Dis Vol. 22, Suppl 1, p116, P141, 1999.
  9. Eraksoy M, E. Öge, Z. Yapici, E. Deniz, F. Erdoğan ve M. Barlas, “Lambert-Eaton myastenic syndrome in childhood: A case report,” 9th Europan Neurological Society Meeting, June 5-9, 1999, Milan, Italy. J Neurol Vol. 246, Suppl. 1, I/143, P707, 1999.
  10. Yapici Ucgul Z, E. Deniz, F. Erdoğan, M. Barlas, M. Eraksoy ve H. Ozcan, “Leukodystrophy in 40 children: Clinical features, MRI/MRS, follow-up,” 3rd Congress of the European Paediatric Neurology Society, November 7-10, 1999 - Nice, France. Eur J Paediatr Neurol Vol. 3, N 6, A107, 223, 1999.
  11.  Yapici Ucgul Z, A. Dincer, M. Barlas ve M. Eraksoy, “L-2-Hydroxyglutaric Aciduria: Clinical heterogeneity, MRI/MRS findings in 5 Turkish patients,” 3rd Congress of the European Paediatric Neurology Society, November 7-10, 1999 - Nice, France. Eur J Paediatr Neurol Vol. 3, N 6, A108, 221, 1999.
  12. Yapici Ucgul Z, C. Gulal, D. Kınay, F. Darendeliler, A. Gokyigit ve M. Eraksoy, “A case of pseudohypoparathyroidism type 1a: Phenotypical features, epilepsy and EEG” 3rd Congress of the European Paediatric Neurology Society, November 7-10, 1999, Nice, France. Eur J Paediatr Neurol Vol. 3, N 6, A48, 222, 1999.
  13. Erdogan F, Z. Yapici, E. Deniz, M. Barlas, Y. Parman, M. Ertaş, H. Ozcan ve M. Eraksoy, “Infantile neuroaxonal dystrophy: Report of two cases,” 3rd Congress of the European Paediatric Neurology Society Congress, November 7-10, 1999, Nice, France. Eur J Paediatr Neurol Vol. 3, N 6, A113, 270, 1999.
  14. Erdogan F. E. Deniz, Z. Yapici, M. Barlas, M. Ertaş, H. Ozcan ve M. Eraksoy, “Congenital myastenic syndromes,” 3rd Congress of the European Paediatric Neurology Society, November 7-10, 1999 - Nice, France.  Eur J Paediatr Neurol Vol. 3, N 6, A113, 269, 1999.
  15. Eraksoy M, M. Barlas, Z. Yapici, F. Erdoğan, E. Deniz ve H. Ozcan, “Childhood-Onset dystonia: Clinical and neurological findings in 31 children,” 10th Meeting of the Europan Neurological Society, June 18-22, 2000 - Jerusalem, Israel. J Neurol Vol. 247, Suppl 3, III/34, 100, 2000. (Oral presentation)
  16. Eraksoy M, A. Kiyat Atamer, G. Saruhan Direskeneli, G. Akman Demir, Z. Yapici ve R. Tuncay, “The frequency of CSF oligoclonal bands and MRI lesions in multipl sclerosis before 16 years,” 10th Meeting of the Europan Neurological Society, June 18-22, 2000 - Jerusalem, Israel. J Neurol Vol. 247, Suppl. 3, III/37, P546, 2000.
  17. Eraksoy M, G. Akman Demir, Z. Yapici, N. Turan, N. Isik, T. Seleker, F. Seleker, N. Sütlas, R. Kuruoglu, H. Tireli, A. Siva, B. Petek Balci ve F. Öztürk, “Survey of multipl sclerosis in Istanbul,” 11th Meeting of the Europan Neurological Society, April 21-25, 2001 – Paris. J Neurol Vol. 248, Suppl. 2, II/158, P626, 2001.
  18. Yapici Z, ve M. Eraksoy, “Opercular syndrome: clinical and MRI features in five children,” 4th Congress of the European Paediatric Neurology Society, 12-16 September, 2001, Baden Baden, Germany. Eur J Paediatr Neurol Vol. 5, N 5, A119, P294, 2001.
  19. Parman Y, M. Poyraz, I. Baris, B. Bilir, E. Battaloglu, Z. Yapici, M. Eraksoy, V. Plante-Bordeneuve, A. Guiochon-Mantel, P. Serdaroglu ve F. Deymeer, “Clinical and genetic study of 10 cases with early-onset demyelinating neuropathy including one with a mutation in periaxin gene,” 12nd Meeting of the Europan Neurological Society, 2002. J Neurol Vol. 249, Suppl. 1, I/150, P584, 2002.
  20. Eraksoy M, N. Turan, M. Kurtuncu, G. Akman Demir, A. Kiyat Atamer, Z. Yapici ve H. Ozcan, “Demographic and clinical findings in familial multipl sclerosis: a hospital-based study,” 12nd Meeting of the Europan Neurological Society, 2002. J Neurol Vol. 249, Suppl. 1, I/113, P430, 2002.
  21. Eraksoy M, N. Turan, G. Akman Demir, Z. Yapici, E. Deniz, C. Bayindir ve H. Ozcan, “Clinical, cerebrospinal fluid and neuroimaging findings of opticospinal involvement in the spectrum of inflammatory demyelinating diseases,” 12nd Meeting of the Europan Neurological Society, 2002. J Neurol Vol. 249, Suppl. 1, I/113, P431, 2002.
  22. Eraksoy M, N. Turan, M. Kurtuncu, A. Kiyat, Z. Yapici, G. Akman Demir, Immunomodulatory therapies in familial multiple sclerosis. ECTRIMS-ACTRIMS, Baltimore, Multipl Sclerosis S69: P156, 2002.
  23. Ismihanoglu B, Z. Yapici, A. Dincer ve M. Eraksoy, “A case with a different kind of corpus callosum lesions,” 8th Prague International Symposium of Child Neurology, p112, 22-25 March, Prague, 2003.
  24. Ayta S, Z. Yapici, C. Gurses, SG. Sismanlar, UI. Alkac ve M. Eraksoy, “Rett Syndrome: Clinical and Electrophysiological Features in 5 Turkish Children,” 8th Prague International Symposium of Child Neurology, p141, 22-25 March, Prague, 2003.
  25. Parman Y, E. Battaloglu, I. Baris, B. Bilir, M. Poyraz, N. Bissar-Tadmori, A. Williams, Z. Yapici, M. Eraksoy, P. Serdaroglu, F. Deymeer, PJ. Brophy ve G. Said, “Clinicopathological and Genetic Study of Early-Onset Demyelinating Neuropathy,” American Academy of Neurology, 55th Annual Meeting, March 29-April 4, 2003, Honolulu, Hawaii. Neurology Vol. 60, Suppl. 1, N 5, A275, P04.026, 2003.
  26. Yapici Z, B. Ismihanoglu, A. Dincer, G. Gursoy, S. Ayta ve M. Eraksoy, “Pelizeaus-Merzbacher Disease: Clinical Profile, VEP, MRI, and MR-Specroscopy in 8 Turkish Children,” American Academy of Neurology, 55th Annual Meeting, March 29, April 4, 2003, Honolulu, Hawaii. Neurology Vol 60, Suppl 1, N 5, A442, P06.004, 2003.
  27. Yapici Z, A. Dincer ve M. Eraksoy, “Septo-optic dysplasia associated with hypoplasia of the right cerebellar hemisphere and schizencephaly,” 13th Meeting of the European Neurological Societ, 14-18 June, 2003 – Istanbul. J Neurol Vol. 250, Suppl. 2, II/68, P236, 2003.
  28. Okan F, Z. Yapici, O. Erkan ve A. Nuhoglu, “Neurodevelopmental outcome in 50 preterm infants,” 13th Meeting of the European Neurological Society, 14-18 June 2003 –Istanbul. J Neurol Vol. 250, Suppl. 2, II/66, P230, 2003.
  29. Yapici Z, N. Dortcan, A. Dincer, A. Gokyigit, C. Baykal ve M. Eraksoy, Neurological and systemic aspects of tuberous sclerosis in relation to MRI/MRS findings in 11 children,” 13th Meeting of the European Neurological Society, 14-18 June 2003 – Istanbul. J Neurol Vol. 250, Suppl. 2, II/67, P231, 2003.
  30. Eraksoy M, M. Kurtuncu, Z. Yapici, F. Bilgili, G. Akman Demir ve H. Ozcan, “Clinical, radiological and cerebrospinal fluid findings of acute disseminated encephalomyelitis in children and adults,”13th Meeting of the European Neurological Society 14-18 June 2003, Istanbul. J Neurol Vol. 250, Suppl. 2, II/82, P295, 2003.
  31. Eraksoy M, N. Turan, G. Akman Demir, M. Kurtuncu, Z. Yapici, F. Bilgili ve H. Ozcan, “Survival, prognostic factors, magnetic resonance imaging and cerebrospinal fluid      findings in early-onset multiple sclerosis,” 13th Meeting of the European Neurological Society 14-18 June 2003 – Istanbul. J Neurol Vol. 250, Suppl. 2, II/196, P759, 2003.
  32. Yapici Z, A. Demirtas A, G. Gursoy ve M. Eraksoy, “Gray matter heterotopia in 31 children,” 5th Congress of the European Pediatric Neurology Society, 22-25 Oct 2003, Taormina, Italy. Eur J Paediatr Neurol Vol. 7, N 5, 309 (P 106), 2003.
  33. Yapici Z, G. Babacan, G. Gursoy ve Eraksoy M, “Clinical and MRI features in 14 children with schizencephaly,” 5th Congress of the European Pediatric Neurology Society, 22-25 Oct 2003, Taormina, Italy. Eur J Paediatr Neurol Vol. 7, N 5, 309 (P 105), 2003.
  34. Orhan EK, S. Basgul, Z. Yapici, O. Uneri ve M. Eraksoy, “Classification of Childhood Headache and Evaluation of Depression, Anxiety and Self Respect Scales,” VI. International Congress on Headache in Children and Adolescents, 21-25April, 2004 –Vienna, Austria. The Journal of Headache and Pain Vol. 5 (1), p67, P12, 2004.
  35. Saruhan-Direskeneli G, S.P. Yentür, V. Demirbilek, G. Yılmaz, Ö. Çokar, E. Önal, Z. Yapici, G. Akman Demir, A. Gokyigit ve C. Gürses, “Cytokines and Chemokines in Subacute Sclerosing Panencephalitis (SSPE),” International Society of Neuroimmunology, 7th International Congress, p37, 120, Sep 28 - Oct 2, Venice, Italy, 2004.
  36. Yentür SP, C. Gürses, V. Demirbilek, G. Yılmaz, E. Önal, Z. Yapici, Ö. Çokar, A. Gokyigit ve G. Saruhan-Direskeneli, “No response against myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and alpha-B-crystallin in subacute sclerosing panencephalitis (SSPE),” International Society of Neuroimmunology, 7th International Congress, p45, 149, Sep 28 - Oct 2, Venice, Italy, 2004.
  37. Yentür SP, C. Gürses, V. Demirbilek, G. Yılmaz, E. Önal, Ö. Çokar, Z. Yapici, A. Gokyigit ve G. Saruhan-Direskeneli, “Immun response to myelin antigenes and measles vaccine in sclerosing panencephalitis,” 12th International Congress of Immunology and 4th Annual Conference of FOCIS, July 18-23, 2004, Montreal, CANADA. Clinical and Investigative Medicine Vol. 27, N 4, T46.136, 2004.
  38. Eraksoy M, Z. Yapici, S. Ayta, G. Akman Demir, B. Bilgili, B. Topçular ve Ozcan H, “Disease-modifying treatment in children and adolescents with multiple sclerosis,” 14th Meeting of the European Neurological Society, 26-30 June, 2004. J Neurol Vol. 251, Suppl. 3, III/62, P225, 2004.
  39. Topçular B, N. Sözer, S. Ayta, Z. Yapici, G. Akman-Demir ve M. Eraksoy, “Tumour-like inflamatory demyelinating lesions: intermediate entitiy between multiple sclerosis and acute disseminated encephalomyelitis?” 20th Congress of the European Committee for Treatment and Resesarch in Multiple Sclerosis, 9th Annual Meeting of Rehabilitation in MS, October 6-9, 2004, Vienna. Multiple Sclerosis Clinical and Laboratory Rsesarch Vol. 10, Suppl. 2, Abs 28, 2004 (oral presentation).
  40. Bilir B, Z.Yapici ve E. Battaloglu, “Analysis of the proteolipid protein gene in patients with PMD,” European Human Genetics Conference 2004. Eur J Hum Genet Vol. 12-15, Suppl. 1, P0770, 2004.
  41. Bilir B, Z. Yapici, C. Yalcinkaya ve E. Battaloglu, “Genetic Heterogeneity of Pelizaeus-Merzbacher Disease: Exclusion of Linkage to the Proteolipid Protein1 Locus in Three Affected Families,” European Human Genetics Conference 2005, Prague. Eur J Hum Genet Vol. 18, Suppl. 1, p306, P1039, 2005.
  42. Topcular B, E. Tufan, N. Sozer Topcular, Z. Yapici, N. Yesilot, G. Akman Demir ve M. Eraksoy, “Cognitive impairment in early-onset multipl sclerosis: a preliminary study,” 15th Meeting of the European Neurological Society, 18-22 June, 2005. J Neurol Vol. 252, Suppl. 2, II/109, P413, 2005.
  43. Ugur SA, Z. Yapici, A. Tolun, “Locus and Gene Analysis in a Novel Autosomal Recessive Leukodystrophy”, European School of Genetic Medicine, 18. Course of Medical Genetics, Bertinoro di Romagna, Italy, May 15-21, 2005.
  44. Yapici Z, B. Bilir, Y. Değirmenci, M. Emre, “Hallervorden-Spatz syndrome with the onset of jaw opening dystonia”, 10th International Child Neurology Congress, 11-16 June, 2006. Neuropediatrics vol. 26, Suppl. S1, TP114, 2006. 
  45. Yapici Z, HA. Erdaoğan, E. Tuzun, V. Altunayoglu, H. Issever, M. Eraksoy “Plasma cytokine levels in juvenile myastenia gravis: 11 patients”, XI. International Congress on Neuromuscular Diseases, 2-7 July 2006. Neuromuscular Disorders Vol.16, Suppl 1, S180, NMJ-P-3.06, 2006.
  46. Bilir B, Z. Yapici, C. Yalcinkaya, E. Battaloglu, “Mutation and linkage analyses of the Proteolipid Protein 1 gene in patients with Pelizaeus-Merzbacher disease”, XI. International Congress on Neuromuscular Diseases, 2-7 July 2006. Neuromuscular Disorders Vol.16, Suppl 1, S127, G-P-2.06, 2006.
  47. Yapici Z, B. Bilir, C. Yalcinkaya, U. Isoglu-Alkac, E. Battaloglu, M. Eraksoy, “Clinical profile in GJA12 mutations: nine Turkish children”, 59th Annual Meeting of American Academy of Neurology, April 28-May 5, Boston, 2007. Neurology Vol 68, suppl 1, number 12, A46, P02.010, 2007.
  48. Yapici Z, K. Alpay, D. Yalcin, H. Hanagasi, M. Eraksoy, “Clinical aspects of L-2-HGA in 13 Turkish children”, 17th Meeting of the European Neurological Society, June 16-20, Rhodos, J Neurol Vol. 254, suppl 3, III/97, P387, 2007.
  49. Eraksoy M, G. Akman-Demir, Z. Yapici, M. Kurtuncu, M. Mutlu, B. Topcular, H. Durmus, H. Ozcan, “The use of IFNB-1b theraphy before and after 16 years of age in children with multipl sclerosis: a prospective follow-up”, 17th Meeting of the European Neurological Society, June 16-20, Rhodos, J Neurol Vol. 254, suppl 3, III/39, O158, 2007 (oral presentation).
  50. Eraksoy M, G. Akman-Demir, M. Kurtuncu, Z. Yapici, M. Mutlu, B. Topcular, H. Durmus, H. Ozcan, “Devic’s neuromyelitis optica: a prospective study”, 17th Meeting of the European Neurological Society, June 16-20, Rhodos, J Neurol Vol. 254, suppl 3, III/36, O147, 2007 (oral presentation).
  51. Kurtuncu M, M. Pehlivan, H. Durmus, M. Mutlu, N. Yesilot, F. Korkmaz, B. Topcular, Z. Yapici, G. Akman-Demir, M. Eraksoy, “Demographic and clinical statistics of multipl sclerosis and demyelinating diseases in an outpatients clinic, İstanbul Faculty of Medicine”, 23th Congress of the European Committee for Treatment and Research in Multipl Sclerosis and the 12th Annual Conference of Rehabilitation in MS, 11-14 October, Prague, Multipl Sclerosis Vol. 13, suppl 2, P348, 2007.
  52. Durmus H, M. Kurtuncu, Z. Matur, M. Pehlivan, M. Mutlu, Z. Yapici, G. Akman-Demir, M. Eraksoy, “Epileptic seizures in multipl sclerosis”, 23th Congress of the European Committee for Treatment and Research in Multipl Sclerosis and the 12th Annual Conference of Rehabilitation in MS, 11-14 October, Prague, Multipl Sclerosis Vol. 13, suppl 2, P405, 2007.
  53. Eraksoy M, M. Kurtuncu, G. Akman-Demir, Z. Yapici, M. Mutlu, B. Topcular, A. Tumac, U. Tuzun, M. Calay, H. Durmus, H. Ozcan, “Clinically unsuspected multipl sclerosis: report of 22 cases and review of the literature”, 23th Congress of the European Committee for Treatment and Research in Multipl Sclerosis and the 12th Annual Conference of Rehabilitation in MS, 11-14 October, Prague, Multipl Sclerosis Vol. 13, suppl 2, P357, 2007.
  54. Akman-Demir G, M. Eraksoy, E. Tuzun, S. Jarius, S. Icoz, M. Kurtuncu, P. Waters, Z. Yapici, M. Mutlu, A. Vicent, “Devic’s Neuromyelitis Optica: An NAlysisi of 47 Patients and Prognostic Implications of NMO IgG Status”, 60th Annual Meeting of AAN, April 12-19, Chicago, Neurology Vol. 70 (Suppl 1), P05.057, A267, 2008.
  55. Yapici Z, G. Benbir, S Saltik, B. Ertugrul, S. Naidu, C. Yalcinkaya, “Two cases with progressive cavitating leukoencephalopathy” International Conference on Diagnosis and Treatment in Pediatric Neurology, Warsow, Poland, 2008, 14-17 May, OP 05. European Journal of Pediatric Neurology Vol 12 (Supl 1), S14, 2008 (oral presentation).
  56. Alp R, Sİ. Alp, Y. Palancı, H. Sur, U.T. Boru, A. Ozge, Z. Yapici, “The prevalence of Headache in School Children in Agri, East of Turkey”, VII. International Congress on Headache in Children and Adolescents, 17-21 May, İstanbul, Cephalalgia Vol 28, P 06, p. 443-444, 2008.
  57. Alp R, Sİ Alp, A. Ozge, Z. Yapici, “Headache Etiology in Children: A prospective Study of 155 Cases”, VII. International Congress on Headache in Children and Adolescents, 17-21 May, İstanbul, Cephalalgia Vol 28, P 48, p. 458, 2008.
  58. Akman-Demir G, S. Saip, D. Uluduz, M. Kurtuncu, E. Seyahi, I. Tugal-Tutkun, Z. Yapici, H. Ozdogan, M. Eraksoy, A. Gul, H: Yazici, A. Siva, “Pediatric Neuro-Behcet’s syndrome”, 13th International Conference and 5th Patients’ Consention on Behçet’s Disease, 24-27 May, Portscach Klagenfurt, Austria, Clinical and Experimental Rheumatology Vol. 26, F2, S-32, 2008 (oral presentation).
  59. Caglayan H, O. Yalcin, N. Bebek, K. Agan, Z. Yapici, D. Yalcin, G. Dizdarer, D. Turkdogan, C. Ozkara, A. Unalp, D. Uluduz, G. Gul, D. Kuscu, S. Ayta, K. Tutkavul, S. Comu, C. Meral, B. Baykan, “A susceptibility locus for juvenile absance epilepsy”, Human Genome Meeting, p 229, P 512, September 27th-30th, 2008.
  60. Yalcin O, B. Baykan, N. Bebek, K. Agan, Z. Yapici, D. Yalcin, G. Dizdarer, D. Turkdogan, C. Ozkara, A. Unalp, G. Gul, D. Kuscu, S. Ayta, K. Tutkavul, C. Meral, S. Comu, SH Caglayan, “An association analysis for idiopathic absence epilepsy in 2q36 in the Turkish population”, 3rd ESF Functional Genomics Conference, October 1-4, Innsbruck, Austria, p 85, P60, 2008.
  61. Eraksoy M, Z. Yapici, G. Akman-Demir, H. Ozcan, “Clinical and laboratory findings in children with neuromyelitis optica: a long-term follow-up”, 19th Meeting of the European Neurological Society, June 20-24, Milan, O 145, 2009 (oral presentation).
  62. Eraksoy M, Z. Yapici, G. Akman-Demir, H. Ozcan, “Clinically unsuspected multiple sclerosis in children: a long-term follow-up”, 19th Meeting of the European Neurological Society, June 20-24, Milan, P 510, 2009.
  63. Yapici Z, I. Yazici, R. Surmeli, M. Eraksoy, C. Yalcinkaya, “A case of a new leukoencephalopathy with brain-stem and spinal cord involvement”, 19th Meeting of the European Neurological Society, June 20-24, Milan, P 511, 2009.
  64. Yazici I, Z. Yapici, B. Baykan, F. Akyan, K. Alpay, H. Hanagasi, D. Yalcin, M. Van der Knaap, M. Eraksoy, “Clinical and electroencephalographic aspects of 16 Turkish patients with L2 hydroxyglutaric aciduria”, 13th Congress of the European Federation of Neurological Societies, Septemer 12-16, Florence, P2449, European Journal of Neurology, Vol 16, Supplement 3, September 2009.
  65. Eraksoy M, S Ayta, Z Yapici, G Akman-Demir, H Ozcan, “Early IFNB-1b therapy in children with multipl sclerosis: a prospective study”, 19th world congress of neurology, 24-30 october 2009, Bangkok, Thailand; J Neurological Sci, vol 285 (suppl 1), S95, FP24-TU-03, 2009.
  66. Uluduz D, Kurtuncu M, Siap S, Yapici Z, Akman-Demir G, Siva A, “Clinical characteristics of paediatric onset neuro-Behcet’s disease”, 20th Meeting of the European Neurological Society, June 19-23, Berlin, O 92, 2010 (oral presentation).
  67. Eraksoy M, Pulur N, Yapici Z, Gurses C, “Vitamin B12 deficiency, involuntarry movements and seizure in a 11-months-old boy: a case report and review the literature”, 20th Meeting of the European Neurological Society, June 19-23, Berlin, O 96, 2010 (oral presentation).
  68. Eraksoy M, Akman-Demir G, Yapici Z, Gunduz T, Kurtuncu M, “Familial effects on the age of onset, initial symptoms and clinical courses of multipl sclerosis”, 20th Meeting of the European Neurological Society, June 19-23, Berlin, P 233, 2010.
  69. Topaloglu-Tekturk P, Yapici Z, Eraksoy M, Dincer A, van der Knaap M. A vanishing white matter case with clinical, genetic and diffusion tensor imaging findings. 14th Congress of the EFNS, Geneva, Switzerland, September 25-28, P 2445, p 515, 2010.
  70. Topaloglu-Tekturk P, Aydın Z, Yapici Z, Eraksoy M. A childhood multipl sclerosis case presenting with syringomyelia and posterior cord findings. 9th Congress of the EPNS, Cavtat, Croatia, May 11-14, Eur J Paediatr Neurol, S111, P19.13, 2011.
  71. Eraksoy M, Gürses C, Tektürk P, Yapici Z, Bayındır C, Bavbek B, Ozcan H. Neurocutenus melanosis in association with andy-Walker variant in a 4-year-old boy: clinical, radiological, necropsy findings and review of the literature. 21st Meeting of the ENS, 28-31 May, Lisbon, Portugal, J Neurol, Vol 258, Suppl 1, S234, P828, 2011.
  72. Tektürk P, Guzel V, Yapici Z, Kayserili H, Eraksoy M. A child with Niemann-Pick type C presenting with antiepileptic drug-rsistant epilepsy and treatment with miglustat. 21st Meeting of the ENS, 28-31 May, Lisbon, Portugal, J Neurol, Vol 258, Suppl 1, S231, P820, 2011.
  73. Gunduz T, Topaloglu Tekturk P, Eraksoy M, Yapici Z. A case of MRI negative neurobrucellosis with spinal cord involvement.  12th International Child Neurology Congress, Brisbane Convention Center, May 27 – June 1, Australia, 2012.
  74. Kaymaz Önalan A, Tektürk P, Yapıcı Z.  MPAN: A New Subtype of NBIA; Mitochondrial Membrane Protein-Associated Neurodegeneration. 10th European Paediatric Neurology Society Congress, Brussels (Belgium) September 25-28, 2013.
  75. Tektürk P, Erdoğan ET, Kurt A, Kucuk Z, Aksu S, Karamursel S, Yapici Z, Baykan B. Transcranial direct current stimulation for seizure control in patients with Lennox-Gastaut syndrome. EP2229. Joint congress of ENS and EFNS, Istanbul, TURKEY, May 31- June 3, 2014.
  76. Uyar T, Tekturk P, Yapici Z, Eraksoy M, Gokyigit A. Fixation loss sensitivity in a child patient with symptomatic occipital epilepsy: a case prsentation. PP3134. Joint congress of ENS and EFNS, Istanbul, TURKEY, May 31- June 3, 2014.
  77. Yapici Z, Tekturk P, Tuschl K, Eraksoy M, Barlas M, Ozcan H. A case with autosomal recessive hypermanganesemia: clinical and MRI findings. PP4126. Joint congress of ENS and EFNS, Istanbul, TURKEY, May 31- June 3, 2014.
  78. Yapici Z, Tekturk P, Ertan S, Citak A, Sık G, Aydin S. Long term follow-up results of two dbs implanted pkan cases. 4th international symposium on paediatric movement disorders, P52, p 71, Barcelona, SPAIN, February 19-20, 2015.
  79. Erer S, Yapici Z, Tuzun E, Giris M, Durana S, Taskaipioglu O, Okan M. A case of hyperkinetic movement disorder associated with LGI1 antibodies. 4th international symposium on paediatric movement disorders, P51, p 70, Barcelona, SPAIN, February 19-20, 2015.
  80. Yapici Z, Tekturk P, Ertan S, Citak A, Sık G, Akcakaya H, Eraksoy M, Aydin S. DBS-implanted PKAN cases: Two clinical observations, 11th EPNS Congress, PP12.5-2798 (S 78), Vienna, Austria, 27-30 May 2015.
  81. Akcakaya H, Tekturk P, Tur EK, Eraksoy M, Yapici Z. Atypical eneterovirus encephalitis causing behavioral changes and Autism-like clinical manifestations: case report, 11th EPNS Congress, P103-2340 (S 123), Vienna, Austria, 27-30 May 2015.
  82. Tekturk P, Erdoğan ET, Kurt A, Vanlı-Yavuz EN, Kocagoncu E, Kucuk Z, Aksu S, Yapici Z, Baykan B, Karamursel S.  Comparison of the effect of transcranial direct current stimulation between focal and generalized epilepsy syndromes. P0832. 31th International Epilepsy Congress, Istanbul, TURKEY, September 05-09, 2015.
  83. Jacqueline A. French, John A. Lawson, Zuhal Yapici, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J. de Vries, Noah Berkowitz, Maurizio Voi, Neva Coello, Wing Cheung, David N. Franz. Adjunctive Everolimus Therapy for the Treatment of Refractory Partial-Onset Seizures Associated With Tuberous Sclerosis Complex: Results From a Randomized, Placebo-Controlled, Phase 3 Trial. 68 th Annual Meeting of the American Academy of Neurology (AAN) on April 15-21, PL02.007-Clinical Trials Plenary, Vancouver, Canada, 2016 (Oral presentation).
  84. Jacqueline A. French, John A. Lawson, Zuhal Yapici, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J. de Vries, Noah Berkowitz, Maurizio Voi, Neva Coello, Wing Cheung, David N. Franz. Exposure-response Analysis of Adjunctive Everolimus Therapy in Patients with Seizures Associated with Tuberous Sclerosis Complex (TSC). European Academy of Neurology (EAN) congress on May 28- 31, 2016 (Oral presentation).
  85. Yapici Z, Tekturk P, Artuch-Iriberri, Bastan B, Eraksoy M. A different clinical manifestation of a disorder of tetrahydrobiopterin (BH4) metabolismin two siblings. 14th International Child Neurology Congress on May 1-5, Amsterdam, Netherlands, 2016.
  86. John Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Pi-Chuan-Fan, Rima Nabbout, Paolo Curatolo, Petrus de Vries, Noah Berkowitz, Maurizio Voi, Severine Peyrard, Alexandra Vaury, David N. Franz. Efficacy and safety of adjunctive everolimus therapy in Asian patients with refractory partial-onset seizures associated with TSC in EXIST-3. 15th Asian & Oceanian Congress of Neurology (AOCN) on August 18 – 21, Kuala Lumpur, Malaysia, 2016 (Oral presentation).
  87. Nihan Hande Akcakaya, Sibel Uğur Iseri, Esra Battaloglu, Pinar Tekturk, Hasmet Hanagası, Mefkure Eraksoy, Ugur Ozbek, Zuhal Yapici. Clinical and Genetic Features of PKAN Patients in a Tertiary Center in Turkey. European Conference of Human Genetics Congress, 2016-A-2868-ESHG, 21-24 May, Barcelona, Spain, 2016.
  88. Petrus J. de Vries, John A. Lawson, Zuhal Yapici, Tilman Polster, Rima Nabbout, Paolo Curatolo, Noah Berkowitz, Maurizio Voi, Severine Peyrard, Alexandra Vaury, Jacqueline A. French. Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex (oral presentation).  19th SSBP (Society of Social and Behavioral Phenotypes) International Research Symposium, 9th-11th September, Siena, Italy, 2016.
  89.  Jacqueline A French, John A Lawson, Zuhal Yapici, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J de Vries, MRCPsych, Noah Berkowitz, Maurizio Voi, Diana Pelov, Severine Peyrard, David N Franz..Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated With Tuberous Sclerosis Complex: Results From a Randomized, Placebo-controlled, Phase 3 Trial (Poster S 104). American Neurological Association (ANA) Annual Meeting, Oct 14-16, Baltimore, USA, 2016.
  90.  Yapıcı Z, Kılınçaslan A, Aydın S, Kök BE, Akçakaya H. Pallidal stimulation in a 11-Year-Old Boy with Treatment Resistant Tourette Syndrome. 5th international symposium on paediatric movement disorders, P31, p58, Feb 2-3, Barcelona, Spain, 2017.
  91. David N Franz, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J de Vries, Dennis J Dlugos, Maurizio Voi, Jenna Fan, Severine Peyrard, Diana Pelov, Jacqueline A French. Sustained seizure reduction with adjunctive everolimus for treatment-refractory seizures associated with tuberous sclerosis complex (TSC): Long-term results from the EXIST-3 phase 3 study. 69th American Academy of Neurology Annual Meeting, April 22-28, Boston, USA, 2017 (oral presentation).
  92. Paolo Curatolo, David N Franz, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Petrus J de Vries, Dennis J Dlugos, Jenna Fan, Severine Peyrard, Diana Pelov, Maurizio Voi, Jacqueline A French. Sustained reduction in seizure frequency with adjunctive everolimus for treatment-refractory seizures associated with tuberous sclerosis complex (TSC) in children under 6 years of age: Results from the phase 3 EXIST-3 extension phase. 12th European Paediatric Neurology Society (EPNS) Congress, June 20 to 24, Lyon, France, 2017 (oral presentation).
  93. David N. Franz, John A. Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J. de Vries, Dennis J. Dlugos, Maurizio Voi, Jenna Fan, Severine Peyrard, Diana Pelov, Jacqueline A. French. Sustained Seizure Reduction with Adjunctive Everolimus for Treatment-refractory Seizures Associated with Tuberous Sclerosis Complex (TSC): Long-term Results From the Phase 3 EXIST-3 Study. International Research Conference on TSC and LAM. June 22-24, 2017 in Washington DC, USA, 2017 (oral presentation).
  94. Beşer C, Demir N, Akcakaya NH, Yapıcı Z. Subacute sclerosing panencephalitis presenting with psychiatric symptoms. 27th Turkish Child and Adolescent Psychiatry Congress, Çeşme, İzmir, PP125, 10-13 May, 2017; Turkish Journal of Child and Adolescent Mental Health Supp 1, ISSN 1301-3904, p285, pb 125, 2017.
  95. Demir N, Akcakaya NH, Yapıcı Z. Obbsesive-Compulsive Disorders in a Case with Wilson’s Disease. 27th Turkish Child and Adolescent Psychiatry Congress, Çeşme, İzmir, PP138, 10-13 May, 2017; Turkish Journal of Child and Adolescent Mental Health Supp 1, ISSN 1301-3904, p295, pb 138, 2017.
  96. Akköprü H, Coşkun M, Yapıcı Z. A Case of Tuberous Sclerosis Complex which Shows Regression with Everolimus Treatment. 27th Turkish Child and Adolescent Psychiatry Congress, Çeşme, İzmir, PP186, 10-13 May, 2017; Turkish Journal of Child and Adolescent Mental Health Supp 1, ISSN 1301-3904, p333, 2017.
  97. G. Toksoy, A. Aghayev, G. Bagirova, H. Durmuş Tekçe, &. Avcı, U. Altunoğlu, Y. Parman, P. Oflazer, Z. Yapıcı, H. Kayserili, B. Karaman, S. Başaran, O. Uyguner. 32 novel pathogenic sequence variants in 253 DMD/BMD patients from Turkey. European Human Genetics Conference, May 27-30, Copenhagen, Denmark, 2017.
  98. Jacqueline A French, Paolo Curatolo, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Petrus J de Vries, Dennis J Dlugos, Jenna Fan, Neva Coello, Diana Pelov, Maurizio Voi, David N Franz. Adjunctive everolimus in patients with treatment-refractory seizures associated with tuberous sclerosis complex (TSC): Analysis of exposure-efficacy and exposure-safety relationships in the randomized, phase 3, EXIST-3 trial. 32nd International Epilepsy Congress, September 2 to 6, Barcelona, Spain, 2017 (oral presentation).
  99. Jacqueline A French, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J De Vries, Dennis J Dlugos, Maurizio Voi, Jenna Fan, Severine Peyrard, Diana Pelov, David N Franz. Outcomes In Placebo-Randomized Patients Transitioning To Everolimus During The Extension Phase Of The Exist-3 Trial In Tuberous Sclerosis Complex-Associated Treatment-Refractory Seizures. XXIII. World Neurology Congress (WCN), September 16-21, Kyoto, Japan 2017 (oral presentation).
  100. Adelheid Wiemer-Kruel, David N Franz, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J de Vries, Dennis J Dlugos, Gert Wiegand, Christoph Hertzberg, Maurizio Voi, Jenna Fan, Severine Peyrard, Diana Pelov, Jacqueline A French. Anhaltende Anfallsreduktion mit Everolimus als adjunktive Therapie bei therapierefraktären Anfällen in Zusammenhang mit dem Tuberöse Sklerose Komplex (TSC): Langzeitergebnisse aus der Phase-3-Studie EXIST-3. 90. Kongress der Deutschen Gesellschaft für Neurologie (DGN). September 22 in Leipzig, Germany, 2017 (oral presentation).
  101. David N Franz, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo Petrus J de Vries, Dennis J Dlugos, Maurizio Voi, Jenna Fan, Anne-Laure Louveau, Diana Pelov, Jacqueline A French. Sustained seizure reduction with adjunctive everolimus for treatment-refractory seizures associated with tuberous sclerosis complex (TSC): Long-term results from the EXIST-3 phase 3 study. CNS (2017) Child Neurology Society - 46th Annual Meeting. 24. October 4-6, in Kansas City, USA, 2017 (poster).
  102. David N Franz, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo Petrus J de Vries, Dennis J Dlugos, Maurizio Voi, Jenna Fan, Anne-Laure Louveau, Diana Pelov, Jacqueline A French. Sustained seizure reduction with adjunctive everolimus for treatment-refractory seizures associated with tuberous sclerosis complex (TSC): Long-term results from the EXIST-3 phase 3 study. ANA (2017) American Neurological Association - 142nd Annual Meeting. S207. October 15 – 17, in San Diego, USA, 2017 (poster).
  103. Paolo Curatolo, David N. Franz, John A. Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Petrus J. de Vries, Dennis J. Dlugos, Jenna Fan, Severine Peyrard, Diana Pelov, Maurizio Voi, Jacqueline A. French. Efficacy and Safety of Adjunctive Everolimus for Treatment-Refractory Seizures Associated With Tuberous Sclerosis Complex (TSC) in Children Under 6 Years of Age: Results From the Phase 3 EXIST-3 Extension Phase. American Neurological Association, 142nd Annual Meeting. M201. October 15 – 17, in San Diego, USA, 2017 (poster).
  104. Iseri SU, NH Akçakaya, B Salman, Z Yapici. Exome sequencing identifies a novel FBXO38 variant inherited from a mosaic mother to cause Distal Hereditary Motor Neuronopathy Type IID with distinct features. 67th Annual Meeting of American Society of Human Genetics, 17-21 October, Session S9: Epilepsy/Clinical Neurophysiology (EEG) I on April 22, 2018 at 4:54 PM, Orlando, USA, 2017 (poster).
  105. Franz D, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Mookerjee B, Fan J, Ridolfi A, Herbst F, French J. Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: A Subanalysis of the Phase 3 EXIST-3 Study". Neurology 2018;90 (Suppl 15): S9.007. (The American Academy of Neurology [AAN] 70th Annual Meeting, April 21 to April 27, 2018 in Los Angeles, CA.  Session S9: Epilepsy/Clinical Neurophysiology [EEG] I on April 22, 2018 (The platform presentation number is 007).
  106.    French J, Curatolo P, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, de Vries PJ, Dlugos DJ, Fan J, Coello N, Pelov D, Voi M, Franz DN. Adjunctive Everolimus in Patients with Treatment-refractory Seizures Associated with Tuberous Sclerosis Complex (TSC): Analysis of Exposure-efficacy and Exposure-safety Relationships in the Randomized, Phase 3, EXIST-3 Trial. Neurology. 2018;90 (Suppl 15): S9.004. (The American Academy of Neurology [AAN] 70th Annual Meeting, April 21 to April 27, 2018 in Los Angeles, CA.  Session S9: Epilepsy/Clinical Neurophysiology [EEG] I on April 22, 2018 (The platform presentation number is 004).
  107. Yapici Z, Franz D, Lawson J, Ikeda H, Polster T, Nabbaut R, Curatolo P, de Vries PJ, Dlugos D, Mookerjee B, Fan J, Ridolfi A, Herbst F, French JA. Impact of Mutation Status on Seizure Outcomes in Patients with Tuberous Sclerosis Complex (TSC) Treated in the EXIST-3 Study. Neurology. 2018;90 (Suppl 15): S9.008. (The American Academy of Neurology [AAN] 70th Annual Meeting, April 21 to April 27, in Los Angeles, CA, 2018 (Platform presentation number is 008).
  108. Franz D, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Fan J, Mookerjee B, Peyrard S, pelov D, French J. Long-term efficacy and safety of everolimus as adjunctive therapy in patients with tuberous sclerosis complex (TSC)-associated treatment-refractory seizures: Final analysis of the EXIST-3 study. European Academy of Neurology (EAN Late Breaking Abstract), June 16-19, at Lisbon, Portugal, 2018 (Platform presentation number O424.
  109. Gokalp AU, Uygun O, Akcakaya NH, Yapıcı Z. A Pkan Family Presenting With Night Blindness As The Initial Symptom. 4th EuroSciCon Coference on Neurology&Neurological Disorders, July 12-13, Paris, France, 2018 (poster).
  110. Yapici Z, Fan P-C, Lawson JA, Belousova E, Gazri HE, Ridolfi A, Herbst F, Ikeda H. Long-term safety, rollover study of adjunctive everolimus in patients with tuberous sclerosis complex (TSC)-associated treatment-refractory seizures who continue to benefit from everolimus treatment after completion of EXIST-3. Epilepsia. 2018;59(S3): S3–S353. (13th European Congress on Epileptology (ECE), 26-30 August, Vienna, 2018 (poster).
  111. Polster T, Franz DN, Lawson JA, Yapici Z, Ikeda H, Nabbout R, Curatolo P, deVries PJ, Dlugos D, Fan J, Mookerjee B, Peyrard S, Pelov D, French J. Long-term efficacy and safety of everolimus as adjunctive therapy in patients with tuberous sclerosis complex (TSC)-associated treatment-refractory seizures: Final analysis of the EXIST-3 study. Epilepsia. 2018;59(S3): S-S353. (13th European Congress on Epileptology (ECE), 26-30 August, Vienna, 2018 (oral presentation).
  112. Tristán-Noguero A, Molero M, Wassenberg T, Verbeek M, Willemsen M, Opladen T, Jeltsch K, Pons R, Thony B, Horvath G, Yapici Z, Friedman F, Hyland K, Agosta GE, Artuch R, Borràs E, Sabidó E, García-Cazorla A. Proteomic study on neurotransmitter defects find several biomarkers involved in neurodevelopment dysregulation. SSIEM Annual Symposium, 4-7 September, Athens, O-018. S43, 2018 (oral presentation).
  113. Kuseyri O, Weisbach A, Brugemann N, Klein C, Gizweska M, Karall D, Scholl-Buergi S, Romanoska H, Krzywinska-Zdeb E, Monavari A, Knerr I, Yapici Z, Leuzzi V, Opladen T. Pregnancy management and outcome in patients with four different tetrahydrobiopterin disorders. SSIEM Annual Symposium, 4-7 September, Athens, P-400. S197-198, 2018.
  114. Polster T, Franz D, Lawson J, Yapici Z, Ikeda H, Nabbout R, Curatolo P, de Vries P, Dlugos D, Mookerjee B, Peyrard S, Pelov D, French J. Long-term efficacy and safety of everolimus as adjunctive therapy in patients with tuberous sclerosis complex (TSC)-associated treatment-refractory seizures: Final analysis of the EXIST-3 study. The International Tuberous Sclerosis Complex Research Conference (TSCi), September 13-15, at Tokyo, Japan, 2018 (Poster).
  115. Yapici Z, Franz D, Lawson J, Ikeda H, Nabbout R, de Vries P, Dlugos D, Mookerjee B, Fan J, Jin L, Ridolfi A, Herbst F, French J.  Impact of mutation status on seizure outcomes in patients with tuberous sclerosis complex (TSC) treated in the EXIST-3 study. Annals of Neurology. 2018;84 (suppl 22): S281-S428. (47th Annual Meeting of the Child Neurology Society [CNS], October 15-18 in Chicago, IL, 2018 (Poster).
  116. Franz D, Lawson J, Yapici Z, Ikeda H, Polster T, Nabbout R, de Vries P, Dlugos D, Mookerjee B, Fan J, Lixian J, Ridolfi A, Herbst F, French J. Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC) ‐Associated Treatment-refractory Seizures: Subanalysis of the Phase 3 EXIST‐3 Study. Annals of Neurology. 2018;84 (suppl 22): S281-S428. (47th Annual Meeting of the Child Neurology Society [CNS], October 15-18 in Chicago, IL, 2018. Poster number 35).
  117. Franz D, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Fan J, Mookerjee B, Peyrard S, pelov D, French J. Long-term efficacy and safety of everolimus as adjunctive therapy in patients with tuberous sclerosis complex (TSC)-associated treatment-refractory seizures: Final analysis of the EXIST-3 study. (In French). Congres de la Societe Française de Nerologie Pediatrque, Janu. 16-18, Strasbourg, 2019.
  118. Tristan-Noguero A, Molero M, Wassenberg T, Verbeek M, Yapici Z, Artuch R, Borras E, Sabido E, Garcia-Cazorla A. Proteomic study on neurotransmitter defects find several biomarkers ponting towards neurodevelopment dysregulation. 13th European Paediatric Neurology Society Congress, Oral Communications OC061, Page 59, 17-21 September 2019, Athens, Greece 
  119. Özcan A, Uygun Ö, Aras f; Gultekin M, Yapici Z, Dincer A. QSM Attributes of NBIA Disorders Subtypes in Basal Ganglia. 28th ISMRM Annual Meeting, April 17-20, 2020, Sydney, Australia (oral).
  120. .Ikeda H, Franz D, Lawson JA, Yapici Z, Polster T, Curatolo P, de Vries PJ, Dlugos DJ, Mookerjee B, Ridolfi A, French J. Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures. The Japan society of child neurology (JSCN) annual meeting 2020 (oral).
  121. Susgun S, Demirel M, Yalcin Cakmakli G, Elibol B, Iseri S, Yapıcı Z. Novel WDR45 frameshift variant detected by whole exome sequencing in beta-propeller protein-associated neurodegeneration disease. ESHG 2021 – Virtual Conference, August 28—31, 2021 (poster presentation).
  122. Çakmak ÖÖ, Kamacı İ, Başak AN, Yapici Z. Two siblings with Kufor-Rakeb: A novel Variant in the ATP13A2 Gene. 8th International Symposium on NBIA. 13-15th October, Lausanne, Switzerland (poster presentation), 2022.
  123. Agdere Secil Fatma, Topaloğlu Pınar, Erata Mehmet Can, Karacetin Gul, Yapıcı Zuhal.Immunotherapy In Autısm Spectrum Dısorder; A Case Serıes”  13th International Congress on Psychopharmacology, 0249, Antalya, 9-12 Kasim 2022.
  124. Yalçın Çapan Ö, Yapıcı Z, Çağlayan H. titled"Whole exome sequencing reveals de novo and inherited pathologic variants in developmental and epileptic encephalopathies (DEEs)", Paper ID 217. 4th International Eurasian Conference on Science, Engineering and Technology, Ankara, Turkey, 14-16 December 2022
  125. Quantıtatıve Measurement Of Braın Iron Deposıtıon İn Patıents Wıth Neurodegeneration Of Iron Braın Acumulatıon (NBIA)’ Uygun Özge, İşeri U. Sibel , Özcan Ahmet, Dinçer Alp, Yapıcı Zuhal. 8th European Neurology Congress, Vienne, June 2022.

  126. Ceyhun Sayman, Nalan Capan, Pınar Topaloğlu, Sibel Aylin Uğur Işeri, Sadıka Ozdemir, Barış Baslo, Elif Kocasoy Orhan, Ayşe Resa Aydın, Zuhal Yapıcı, Turkish Nbia Study Group. Multiple Rating Scales in 17 patients with Mitochondrial-membrane Protein Associated Neurodegeneration- Oral Presentation- 17th Congress of the European Forum for Research in Rehabilitation (EFRR), OP 032, Antalya/Türkiye, November 2-5, 2023.

  127. Şahin A, Acar Arslan E, Topaloğlu P, İlhan Algın D, Yapıcı Z and Başak AN. The Molecular Landscape of SMA in Turkey. To be presented at the 4 th International Scientific Congress on Spinal Muscular Atrophy, Ghent, Belgium, 14 th -16 th March 2024

     

 


Sitemizi bugüne kadar 389117 kişi ziyaret etmiştir.


Copyrights © 2024 All Rights Reserved. Powered by drzuhalyapici.com
Kişisel Verilerin Korunması Kanununu

Design By Ceotech

Sınırlı Sorumluluk Beyanı

Web sitemizin içeriği, ziyaretçiyi bilgilendirmeye yönelik hazırlanmıştır. Sitede yer alan bilgiler, hiçbir zaman bir hekim tedavisinin ya da konsültasyonunun yerini alamaz. Bu kaynaktan yola çıkarak, ilaç tedavisine başlanması ya da mevcut tedavinin değiştirilmesi kesinlikte tavsiye edilmez. Web sitemizin içeriği, asla kişisel teşhis ya da tedavi yönteminin seçimi için değerlendirilmemelidir. Sitede kanun içeriğine aykırı ilan ve reklam yapma kastı bulunmamaktadır.© 2024, Tüm hakları saklıdır. Gizlilik Sözleşmesi. Bu web sitesi CEOTECH tarafından yapılmıştır. Daha detaylı bilgi almak için lütfen tıklayınız.

Soru Sor X

Güvenlik Numarası.

“Dosya seç kısmında vereceğiniz kişisel bilgileriniz Kişisel Verilerin Korunması Kanunu (KVKK) madde 6 kapsamında sayılan özel nitelikli kişisel veri niteliğinde olabilmektedir. Bu veriler Kişisel Verileri Koruma Kurulunun yayınladığı “Özel Nitelikli Kişisel Verilerin İşlenmesinde Veri Sorumlularınca Alınması Gereken Yeterli Önlemler” kararına uygun olarak online danışma hizmetinin verilebilmesi amacıyla işlenecek, saklanacak ve aktarılacaktır.”

Kişisel verilerin korunması kanununu okudum anladım (KVKK)
Pazarlama ve istatistik faaliyetleri amaçlarıyla formda verdiğim kişisel verilerin işlenmesine açık rıza veriyorum

Google TranslateX

  • Türkçe
  • English
  • العربية
  • Pусский
  • Spanish
  • France
  • Germany